March 29, 2023
The FDA has approved the first over-the-counter (OTC) Naloxone nasal spray, a move federal officials say will increase the availability of the lifesaving drug.
The FDA authorization of the Narcan nasal spray means the product can be sold directly to consumers in drug, grocery, and convenience stores, gas stations, and online without a prescription, FDA officials said. It would also be the first opioid treatment drug to be available over the counter, according to media reports.
“Today’s approval of OTC naloxone nasal spray will help improve access to naloxone, increase the number of locations where it’s available, and help reduce opioid overdose deaths throughout the country,” FDA Commissioner Robert M. Califf, MD, said on Wednesday.
Here’s what you need to know:
HAP continues to support policies and legislation that address the state’s opioid crisis and improve our behavioral health care system. Learn more about our behavioral health advocacy.
Additional information about the FDA approval is available online.
Tags: Affordable Prescription Drugs | Behavioral Health
Click on topic below for category-specific news articles.
Support a healthier Pennsylvania.